{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Sclerotherapy for Chronic Venous Insufficiency"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised controlled trials and clinical trials"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients with lower limb CVI grades C1-C6."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention was sclerotherapy, compared to placebo, deferred ablation, and ligation therapy."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was quality of life (QoL), measured using the VEINES-QOL scale over 12 months."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not specified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding details were not provided."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 9,670 participants were included, with 5,450 in the intervention group and 4,220 in the control group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Sclerotherapy significantly improved QoL (pooled MD = 10.34, 95% CI 8.78 to 11.90, p < 0.00001) and closure rates (pooled RR = 0.72, 95% CI 0.55 to 0.94, p = 0.001)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}